North America DNA Extraction, Isolation, and Purification Market Forecast to 2030 - Regional Analysis - by Type, Method, Sample Type, Source, Application, and End User
ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦(DNA Extraction, Isolation, and Purification) ½ÃÀåÀº 2022³â¿¡ 17¾ï 3,431¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 34¾ï 2,995¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2022-2030³âÀÇ CAGRÀº 8.9%·Î ÃßÀÌÇÏ¸ç ¼ºÀå ÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
ÃßÃâ, Á¤Á¦ DNAÀÇ »õ·Î¿î ¿ëµµ°¡ ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀ» µÞ¹Þħ
»ý¹°ÇÐÀû »ùÇÿ¡¼ DNA¸¦ ºÐ¸®ÇÏ´Â µ¥ »ç¿ëµÇ´Â DNA ÃßÃâ ±â¼úÀº ±âÃÊ ¿¬±¸¿¡¼ ÀÏ»óÀûÀÎ Áø´Ü ¹× Ä¡·á ÀÇ»ç °áÁ¤¿¡ À̸£±â±îÁö »ý¸í °øÇÐ ÀÀ¿ë ºÐ¾ß¿¡¼ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÃßÃâ, ºÐ¸®, Á¤Á¦µÈ DNA´Â ´Ù¾çÇÑ Áúº´ÀÇ À¯ÀüÀû ¿øÀÎ ¹× °ü¸® ¿¬±¸¿¡ »ç¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ÀýÂ÷´Â ¹ýÀÇÇÐ ¿¬±¸, °Ô³ð ½ÃÄö½Ì, ȯ°æ ¹ÚÅ׸®¾Æ ¹× ¹ÙÀÌ·¯½º °ËÃâ, ºÎÀÚ °ü°è È®¸³ µî¿¡ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ¶ÇÇÑ, Á¶»ó ÃßÀû, ÀÇ·á ½ÃÇè, À¯Àü °øÇаú °°Àº DNA ÃßÃâ ¹æ¹ýÀÇ ÀÀ¿ë ºÎ¹®Àº ´Ù¸¥ ¿©·¯ °¡Áö°¡ ÀÖ½À´Ï´Ù.
ÀÇ·á ºÎ¹®¿¡¼ DNA´Â À¯Àüº´ Áø´ÜÀÇ ±âÃʰ¡µË´Ï´Ù. ¶ÇÇÑ È£¸£¸ó°ú ¹é½Å°ú °°Àº ÀǾàǰ °³¹ß, À§Çè Æò°¡, Ç¥Àû ½ºÅ©¸®´× ¹× Á¶±â ¿¹¹æ Àü·«À» À§ÇÑ ¿¹ÃøÀû À¯ÀüÀÚ ½ÃÇè¿¡µµ µµ¿òÀÌ µË´Ï´Ù.
ȯÀÚ¿¡¼ ÃßÃâÇÑ DNA´Â °â»ó ÀûÇ÷±¸ ºóÇ÷, ³¶Æ÷¼º ¼¶À¯Áõ, ÇåÆÃÅϺ´, ´Ù¿îÁõ°ú °°Àº À¯Àü¼º ÁúȯÀÇ Áø´Ü¿¡ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¼¼°è ȯÀÚ ¼ö Áõ°¡°¡ DNA ÃßÃâ, Á¤Á¦ ŰƮ¿Í °ü·Ã Á¦Ç° ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, DNA´Â ¹é½ÅÀÇ °³¹ß°ú Á¦Á¶(DNA/¾Æ´ÜÀ§ ¹é½Å)¿¡µµ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, BÇü °£¿° ¹é½ÅÀº ÀçÁ¶ÇÕ DNA ±â¼úÀ» »ç¿ëÇÏ¿© Á¦Á¶µË´Ï´Ù. ÀÌ¿Í °°ÀÌ ´Ù¾çÇÑ ¿ëµµ¿¡¼ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ °øÁ¤ÀÇ »ç¿ëÀÌ ±ÞÁõÇÏ°í ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå °³¿ä
ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. ºÐÀÚÀ¯ÀüÇаú ¼¼Æ÷À¯ÀüÇп¡¼ °íµµÀÇ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í, À¯Àü¼º Áúȯ°ú ¾Ï À¯º´·üÀÇ »ó½ÂÀÌ ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¾ÏÇùȸ(American Cancer Society)°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¹Ì±¹¿¡¼´Â 2022³â¿¡ »õ·Ó°Ô 190¸¸¸íÀÇ ¾Ï ȯÀÚ°¡ ¹ß»ýÇØ, 60¸¸ 9,360¸íÀÌ »ç¸ÁÇß½À´Ï´Ù. ´Ù¾çÇÑ º´¸®¸¦ Ä¡·áÇϱâ À§ÇÑ ¸ÂÃãÇü ÀǷᳪ Ç¥Àû ¿ä¹ý¿¡ ´ëÇÑ ÁÖ¸ñÀÇ °íÁ¶´Â À¯ÀüÀÚ ºÐ¼®À» ¼ö¹ÝÇÏ´Â ¿¬±¸ Ȱµ¿ÀÇ ±ÞÁõÀ¸·Î À̾îÁ® DNA ÃßÃâ, Á¤Á¦ Á¦Ç° ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, DNA ÃßÃâ ÀýÂ÷´Â ÀÚµ¿È ¹× ³ôÀº 󸮷® ±â¼ú°ú °°Àº Áøº¸¿¡ ÀÇÇØ °³¼±µÇ¾ú½À´Ï´Ù. ¼±ÁøÀûÀÎ ¼ö¹ý¿¡ ÀÇÇØ DNAÀÇ º¸´Ù Á¤È®Çϰí È¿°úÀûÀÎ ´Ü¸®¿Í Á¤·®ÀÌ °¡´ÉÇÏ°Ô µÇ¾î ¾Ï¼¼Æ÷¿¡¼ ÀϾ°í ÀÖ´Â À¯ÀüÀÚ º¯È¿¡ °üÇÑ Áß¿äÇÑ ¼¼ºÎ»çÇ×ÀÌ ¹àÇôÁ³½À´Ï´Ù. ±× °á°ú, ¿¬±¸¼Ò¿Í ÀÇ·á±â°üÀº º¸´Ù ¸¹Àº ¾çÀÇ »ùÇÃÀ» ó¸®Çϰí Á¤È®ÇÑ °á°ú¸¦ È¿À²ÀûÀ¸·Î ¾ò±â À§ÇÑ ¼³ºñ°¡ °®Ãß¾îÁ® ¿Ô½À´Ï´Ù. ij³ª´Ù ¾ÏÇùȸ(Canadian Cancer Society 2022)¿¡ µû¸£¸é 2022³â Æó¾Ï ¶Ç´Â ±â°üÁö¾ÏÀ» ¾Î°í Àִ ij³ª´ÙÀÎÀº 3¸¸¸í¿¡ ´ÞÇÏ¸ç ½Å±Ô ¾ÏÀ» ¾Î°í Àִ ȯÀÚ ÀüüÀÇ 13%¸¦ Â÷ÁöÇÕ´Ï´Ù. µû¶ó¼ DNA ÃßÃâ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃßÃâµÈ Àç·á´Â ´Ù¾çÇÑ À¯ÇüÀÇ ¾ÏÀ» Áø´ÜÇϱâ À§ÇØ ¿°»öü ÀÌ»óÀ» È®ÀÎÇÏ´Â µ¥ »ç¿ëµÇ±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀÇ·á Àü¹®°¡°¡ À¯ÀüÀÚ ÀÌ»óÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô Çϰí, º¸´Ù ÀûÀº È¿°úÀûÀÎ Ä¡·á Àü·«À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¸ß½ÃÄÚÀÇ À¯¹æ¾Ï À¯º´·ü »ó½ÂÀº Á¤È®ÇÑ À¯ÀüÀÚ ºÐ¼®ÀÇ Á߿伺À» ºÎ°¢½Ã۰í DNA ÃßÃâ ¼ö¿ä¸¦ ´õ¿í ³ô¿©ÁÝ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é À¯¹æ¾ÏÀº ¸ß½ÃÄÚÀÇ ÁÖ¿ä »çÀÎÀ̸ç 2020³â ¸ß½ÃÄÚ¿¡¼ »õ·Î ¹ß°ßµÇ´Â À¯¹æ¾Ï Áõ·ÊÀÇ 15%¸¦ Â÷ÁöÇÕ´Ï´Ù.À¯ÀüÀÚ ÀÌ»óÀÇ Á¶±â ¹ß°ß°ú Á¤È®ÇÑ Æ¯¼ºÈ´Â È¿°úÀûÀÎ Ä¡·á Àü·«À» ¼ö¸³Çϴµ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÌó·³ À¯Àü¼º ÁúȯÀÇ À¯º´·ü »ó½ÂÀº ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀ» Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¼öÀÍ ¹× ¿¹Ãø(-2030³â)(±Ý¾×)
ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸® ¹× Á¤Á¦ ½ÃÀå ¼¼ºÐÈ
ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸® ¹× Á¤Á¦ ½ÃÀåÀº À¯Çü, ¹æ¹ý, »ùÇà À¯Çü, °ø±Þ¿ø, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡¿¡ µû¶ó ±¸ºÐµË´Ï´Ù.
À¯Çüº°·Î´Â ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº ŰƮ, ±â±â, ½Ã¾àÀ¸·Î ºÐ·ùµË´Ï´Ù. 2022³â ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå Á¡À¯À²Àº ŰƮ ºÎ¹®ÀÌ ÃÖ´ë¿´½À´Ï´Ù.
¹æ¹ýº°·Î´Â ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº ÈÇÐÀû ¼ö¹ý°ú ¹°¸®Àû ¼ö¹ýÀ¸·Î ±¸ºÐµË´Ï´Ù. 2022³â ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå Á¡À¯À²Àº ÈÇÐÀû ±â¹ýÀÇ ºÎ¹®ÀÌ ´õ Å®´Ï´Ù. ÈÇÐÀû ¹æ¹ýÀº Æä³î Ŭ·Î·ÎÆ÷¸§, ½Ç¸®Ä«°Ö, ÇÁ·ÎÅ×À̳ªÁ¦ µîÀ¸·Î ¼¼ºÐȵ˴ϴÙ. ¹°¸®Àû ¹æ¹ýÀº Àڱ⠺ñµå¿Í Á¾ÀÌ·Î ´õ ¼¼ºÐȵ˴ϴÙ.
ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº »ùÇà À¯Çüº°·Î Ç÷¾×, ü¾×, ±× ¹Û¿¡ ±¸ºÐµË´Ï´Ù. 2022³â ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå Á¡À¯À²Àº Ç÷¾× ºÎ¹®ÀÌ ÃÖ´ë¿´½À´Ï´Ù.
°ø±Þ¿øº°·Î´Â ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº °Ô³ð°ú ¹Ì»ý¹°·Î ±¸ºÐµË´Ï´Ù. °Ô³ð ºÎ¹®Àº 2022³â ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå¿¡¼ ´õ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¹Ì»ý¹° ºÎ¹®Àº ¹ÚÅ׸®¾Æ¿Í ¹ÙÀÌ·¯½º·Î ¼¼ºÐȵ˴ϴÙ.
¿ëµµº°·Î ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº PCR ½ÃÇè, Â÷¼¼´ë ½ÃÄö½Ì, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ µîÀ¸·Î ºÐ·ùµË´Ï´Ù. Â÷¼¼´ë ½ÃÄö½Ì ºÎ¹®Àº 2022³â ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. PCR Å×½ºÆ® ºÎ¹®Àº qPCR, ¸ÖƼÇ÷º½º PCR, 16S PCR µîÀ¸·Î ¼¼ºÐȵ˴ϴÙ.
ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº Áø´Ü¼¾ÅÍ¡¤¿¬±¸¼Ò, Á¦¾à¡¤¹ÙÀÌ¿À Á¦¾àȸ»ç, CRO, ±âŸ¿¡ ±¸ºÐµË´Ï´Ù. Áø´Ü¼¾ÅÍ¡¤¿¬±¸¼Ò ºÎ¹®ÀÌ 2022³âÀÇ ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå Á¡À¯À²¿¡¼ Ãִ븦 Â÷ÁöÇß½À´Ï´Ù.
±¹°¡º°·Î ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ºÐ·ùµË´Ï´Ù. 2022³â ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀåÀº ¹Ì±¹ÀÌ µ¶Á¡Çß½À´Ï´Ù.
Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc, Illumina Inc, Merck KGaA, Qiagen NV, Takara Bio Inc, Thermo Fisher Scientific Inc, ºÏ¹Ì DNA ÃßÃ⠺и®¡¤Á¤Á¦ ½ÃÀå¿¡¼ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ´ë±â¾÷ÀÔ´Ï´Ù.
¸ñÂ÷
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
- Á¶»ç ¹üÀ§
- 2Â÷ Á¶»ç
- 1Â÷ Á¶»ç
Á¦4Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå-ÁÖ¿ä »ê¾÷ ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ÃßÃâ, Á¤Á¦ DNAÀÇ »õ·Î¿î ¿ëµµ
- À¯ÀüüÇÐÀÇ ¿¬±¸°³¹ß Áõ°¡
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- °øÁ¤ÀÇ °íºñ¿ë°ú ¼÷·Ã ³ëµ¿ÀÚÀÇ Çʿ伺
- ½ÃÀå ±âȸ
- ÇâÈÄ µ¿Çâ
- ¿µÇ⠺м®
Á¦5Àå DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå : ºÏ¹Ì ½ÃÀå ºÐ¼®
- ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¸ÅÃâ(2022-2030³â)
Á¦6Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¸ÅÃâ(-2030³â) ¹× ¿¹Ãø : À¯Çüº°
- ¼Ò°³
- ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå(2022³â, 2030³â) : À¯Çüº° ¸ÅÃâ Á¡À¯À²(%)
- ŰƮ
- ±â±¸
- ½Ã¾à
Á¦7Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¸ÅÃâ(-2030³â) ¹× ¿¹Ãø : ¹æ¹ýº°
- ¼Ò°³
- ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå(2022³â, 2030³â) : ¹æ¹ýº° ¸ÅÃâ Á¡À¯À²(%)
- ÈÇÐÀû ¹æ¹ý
- ¹°¸®Àû ¹æ¹ý
Á¦8Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¸ÅÃâ(-2030³â) ¹× ¿¹Ãø : »ùÇà À¯Çüº°
- ¼Ò°³
- ºÏ¹Ì DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå(2022³â, 2030³â) : »ùÇà À¯Çüº° ¸ÅÃâ Á¡À¯À²(%)
- Ç÷¾×
- ü¾×
- ±âŸ
Á¦9Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¸ÅÃâ(-2030³â) ¹× ¿¹Ãø : °ø±Þ¿øº°
- ¼Ò°³
- ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå(2022³â, 2030³â) : °ø±Þ¿øº° ¸ÅÃâ Á¡À¯À²(%)
- °Ô³ð DNA
- ¹Ì»ý¹° DNA
Á¦10Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¸ÅÃâ(-2030³â) ¹× ¿¹Ãø : ¿ëµµº°
- ¼Ò°³
- ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå(2022³â, 2030³â) : ¿ëµµº° ¸ÅÃâ Á¡À¯À²(%)
- PCR ½ÃÇè
- Â÷¼¼´ë ½ÃÄö½Ì(NGS)
- ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
- ±âŸ
Á¦11Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¸ÅÃâ(-2030³â) ¹× ¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°
- ¼Ò°³
- ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå(2022³â, 2030³â) : ÃÖÁ¾ »ç¿ëÀÚº° ¸ÅÃâ Á¡À¯À²(%)
- Áø´Ü¼¾ÅÍ, ¿¬±¸¼Ò
- Á¦¾àȸ»ç, ¹ÙÀÌ¿ÀÁ¦¾àȸ»ç
- CRO(ÀǾàǰ °³¹ß ¾÷¹« ¼öŹ ±â°ü)
- ±âŸ
Á¦12Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå ¸ÅÃâ(-2030³â) ¹× ¿¹Ãø : ±¹°¡º° ºÐ¼®
Á¦13Àå ºÏ¹ÌÀÇ DNA ÃßÃâ, ºÐ¸®, Á¤Á¦ ½ÃÀå-»ê¾÷ Á¤¼¼
- ¼Ò°³
- À¯±âÀû ¼ºÀå Àü·«
- ¹«±âÀû ¼ºÀå Àü·«
Á¦14Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Bio-Rad Laboratories Inc
- Danaher Corp
- GE HealthCare Technologies Inc
- F. Hoffmann-La Roche Ltd
- Agilent Technologies Inc
- Qiagen NV
- Merck KGaA
- Illumina Inc
- Takara Bio Inc
- Thermo Fisher Scientific Inc
Á¦15Àå ºÎ·Ï
LYJ
The North America DNA extraction, isolation, and purification market was valued at US$ 1,734.31 million in 2022 and is expected to reach US$ 3,429.95 million by 2030; it is estimated to grow at a CAGR of 8.9% from 2022 to 2030.
Emerging Applications of Extracted and Purified DNA Fuels the North America DNA Extraction, Isolation, and Purification Market
The DNA extraction technique used to isolate DNA from biological samples plays a pivotal role in biotechnology applications, ranging from fundamental research to routine diagnostic and therapeutic decision-making. The extracted, isolated, and purified DNA can be used to study the genetic causes and management of various diseases. DNA extraction, isolation, and purification procedures are commonly used in forensic science studies, genome sequencing, spotting environmental bacteria and viruses, and establishing paternity. Furthermore, ancestry tracking, medical tests, genetic engineering, etc., are a few more application areas of the DNA extraction procedures.
In medicine, DNA can serve as a foundation for diagnosing genetic diseases. It is also helping to derive pharmaceutical products such as hormones and vaccines, and predictive genetic testing for risk assessment and the use of targeted screening and early prevention strategies.
The DNA extracted from patients can be used in the diagnosis of genetic diseases such as sickle cell anemia, cystic fibrosis, Huntington's disease, and Down syndrome. Thus, an increase in patient population worldwide contributes to the demand for the DNA extraction and purification kits, and related products. Additionally, DNA is used in vaccine development and manufacturing (DNA/subunit vaccines). For example, Hepatitis B vaccine is prepared using recombinant DNA technology. Thus, an upsurge in the use of DNA extraction, isolation, and purification processes in various applications drives the growth of market.
North America DNA Extraction, Isolation, and Purification Market Overview
The North America DNA extraction, isolation, and purification market has been segmented into the US, Canada, and Mexico. The growing demand for advanced diagnostic tools in molecular genetics and cytogenetics, and the rising prevalence of genetic disorders and cancer fuel the market growth in this region. Data published by the American Cancer Society states that the US recorded ~1.9 million new cancer cases in 2022, while 609,360 cancer deaths were recorded. The increasing focus on personalized medicine and targeted therapies to treat different medical conditions has led to an upsurge in research activities involving genetic analysis, bolstering the demand for DNA extraction and purification products. Further, DNA extraction procedures have improved with advancements such as automation and high-throughput techniques. Advanced methods allow more precise and effective isolation and quantification of DNA, revealing important details about the genetic alterations occurring in cancer cells. As a result, laboratories and medical institutions are better equipped to handle larger volumes of samples and generate precise results efficiently. According to the Canadian Cancer Society 2022, ~30,000 Canadians suffered from lung or bronchus cancer in 2022, accounting for 13% of all new cancer cases. Therefore, demand for DNA extraction is increasing since the extracted material is used to identify chromosomal abnormalities to diagnose various types of cancer. These systems enable healthcare professionals to detect genetic anomalies early, allowing for more targeted and effective treatment strategies. The rising prevalence of breast cancer in Mexico has highlighted the importance of accurate genetic analysis, further bolstering the demand for DNA extraction. According to the World Health Organization (WHO), breast cancer is a leading cause of death in Mexico accounting for ~15% of new breast cancer cases were found in Mexico in 2020. Early detection and precise characterization of genetic anomalies are essential for tailoring effective treatment strategies. Thus, the rising prevalence of genetic disorders significantly driving the DNA extraction, isolation, and purification market in North America.
North America DNA Extraction, Isolation, and Purification Market Revenue and Forecast to 2030 (US$ Million)
North America DNA Extraction, Isolation, and Purification Market Segmentation
The North America DNA extraction, isolation, and purification market is segmented based on type, method, sample type, source, application, end user, and country.
Based on type, the North America DNA extraction, isolation, and purification market is categorized into kits, instrument, and reagent. The kits segment held the largest North America DNA extraction, isolation, and purification market share in 2022.
In terms of method, the North America DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held a larger North America DNA extraction, isolation, and purification market share in 2022. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.
By sample type, the North America DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held the largest North America DNA extraction, isolation, and purification market share in 2022.
By source, the North America DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held a larger North America DNA extraction, isolation, and purification market share in 2022. The microbial segment is further subsegmented into bacteria and virus.
Based on application, the North America DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held the largest North America DNA extraction, isolation, and purification market share in 2022. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.
By end user, the North America DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held the largest North America DNA extraction, isolation, and purification market share in 2022.
Based on country, the North America DNA extraction, isolation, and purification market is categorized into the US, Canada, and Mexico. The US dominated the North America DNA extraction, isolation, and purification market in 2022.
Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc, Illumina Inc, Merck KGaA, Qiagen NV, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America DNA extraction, isolation, and purification market.
Table Of Contents
Table of Content
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America DNA Extraction, Isolation, and Purification Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Emerging Applications of Extracted and Purified DNA
- 4.1.2 Rising R&D in Genomics
- 4.2 Market Restraints
- 4.2.1 High Cost of Process and Need for Highly Skilled Workforces
- 4.3 Market Opportunities
- 4.3.1 New Product Launches and Approvals
- 4.4 Future Trends
- 4.4.1 Technological Advancements Associated with Instruments
- 4.5 Impact Analysis
5. DNA Extraction, Isolation, and Purification Market - North America Market Analysis
- 5.1 North America DNA Extraction, Isolation, and Purification Market Revenue (US$ Mn), 2022 - 2030
6. North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Type.
- 6.1 Overview
- 6.2 North America DNA Extraction, Isolation, and Purification Market Revenue Share, by Type 2022 & 2030 (%)
- 6.3 Kits
- 6.3.1 Overview
- 6.3.2 Kits: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4 Instrument
- 6.4.1 Overview
- 6.4.2 Instrument: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 6.5 Reagent
- 6.5.1 Overview
- 6.5.2 Reagent: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
7. North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Method.
- 7.1 Overview
- 7.2 North America DNA Extraction, Isolation, and Purification Market Revenue Share, by Method 2022 & 2030(%)
- 7.3 Chemical Methods
- 7.3.1 Overview
- 7.3.2 Chemical Methods: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.1 Phenol Chloroform Method
- 7.3.2.2 Phenol Chloroform Method: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.3 Silica Gel Method
- 7.3.2.3.1 Overview
- 7.3.2.3.2 Silica Gel Method: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.4 Proteinase K Method
- 7.3.2.4.1 Overview
- 7.3.2.4.2 Proteinase K Method: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.5 Others
- 7.3.2.5.1 Overview
- 7.3.2.5.2 Others: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Physical Methods
- 7.4.1 Overview
- 7.4.2 Physical Methods: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.1 Magnetic Bead Method
- 7.4.2.1.1 Overview
- 7.4.2.1.2 Magnetic Bead Method: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.2 Paper DNA Method
- 7.4.2.2.1 Overview
- 7.4.2.2.2 Paper DNA Method: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
8. North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Sample Type
- 8.1 Overview
- 8.2 North America DNA Extraction, Isolation, and Purification Market Revenue Share, by Sample Type 2022 & 2030 (%)
- 8.3 Blood
- 8.3.1 Overview
- 8.3.2 Blood: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Body Fluids
- 8.4.1 Overview
- 8.4.2 Body Fluids: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030(US$ Million)
- 8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
9. North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Source.
- 9.1 Overview
- 9.2 North America DNA Extraction, Isolation, and Purification Market Revenue Share, by Source 2022 & 2030 (%)
- 9.3 Genomic DNA
- 9.3.1 Overview
- 9.3.2 Genomic DNA: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Microbial DNA
- 9.4.1 Overview
- 9.4.2 Microbial DNA: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4.2.1 Bacterial
- 9.4.2.1.1 Overview
- 9.4.2.1.2 Bacterial: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4.2.2 Virus
- 9.4.2.2.1 Overview
- 9.4.2.2.2 Virus: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
10. North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by Application.
- 10.1 Overview
- 10.2 North America DNA Extraction, Isolation, and Purification Market Revenue Share, by Application 2022 & 2030 (%)
- 10.3 PCR Test
- 10.3.1 Overview
- 10.3.2 PCR Test: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.2.1 qPCR
- 10.3.2.1.1 Overview
- 10.3.2.1.2 qPCR: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.2.2 Multiplex PCR
- 10.3.2.2.1 Overview
- 10.3.2.2.2 Multiplex PCR: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.2.3S PCR
- 10.3.2.3.1 Overview
- 10.3.2.3.2S PCR: DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.2.4 Others
- 10.3.2.4.1 Overview
- 10.3.2.4.2 Others: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Next Generation Sequencing (NGS)
- 10.4.1 Overview
- 10.4.2 Next Generation Sequencing (NGS): North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.5 Microarray
- 10.5.1 Overview
- 10.5.2 Microarray: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
11. North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - by End User
- 11.1 Overview
- 11.2 North America DNA Extraction, Isolation, and Purification Market Revenue Share, by End User 2022 & 2030 (%)
- 11.3 Diagnostic Center, and Research Laboratories
- 11.3.1 Overview
- 11.3.2 Diagnostic Center and Research Laboratories: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4 Pharmaceutical and Biopharmaceutical Companies
- 11.4.1 Overview
- 11.4.2 Pharmaceutical and Biopharmaceutical Companies: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5 CROs
- 11.5.1 Overview
- 11.5.2 CROs: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
12. North America DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 - Country Analysis
- 12.1 North America: DNA Extraction, Isolation, and Purification Market
- 12.1.1 North America: DNA Extraction, Isolation, and Purification Market, by Country
- 12.1.1.1 US: DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 12.1.1.1.1 US: DNA Extraction, Isolation, and Purification Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.1.2 US: DNA Extraction, Isolation, and Purification Market, by Method, 2020-2030 (US$ Million)
- 12.1.1.1.2.1 US: DNA Extraction, Isolation, and Purification Market, For Chemical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.1.2.2 US: DNA Extraction, Isolation, and Purification Market, For Physical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.1.3 US: DNA Extraction, Isolation, and Purification Market, by Sample Type, 2020-2030 (US$ Million)
- 12.1.1.1.4 US: DNA Extraction, Isolation, and Purification Market, by Source, 2020-2030 (US$ Million)
- 12.1.1.1.4.1 US: DNA Extraction, Isolation, and Purification Market, For Microbial DNA by Source, 2020-2030 (US$ Million)
- 12.1.1.1.5 US: DNA Extraction, Isolation, and Purification Market, by Application, 2020-2030 (US$ Million)
- 12.1.1.1.5.1 US: DNA Extraction, Isolation, and Purification Market, by For PCR Test by Application, 2020-2030 (US$ Million)
- 12.1.1.1.6 US: DNA Extraction, Isolation, and Purification Market, by End User, 2020-2030 (US$ Million)
- 12.1.1.2 Canada: DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 12.1.1.2.1 Canada: DNA Extraction, Isolation, and Purification Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.2.2 Canada: DNA Extraction, Isolation, and Purification Market, by Method, 2020-2030 (US$ Million)
- 12.1.1.2.2.1 Canada: DNA Extraction, Isolation, and Purification Market, For Chemical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.2.2.2 Canada: DNA Extraction, Isolation, and Purification Market, For Physical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.2.3 Canada: DNA Extraction, Isolation, and Purification Market, by Sample Type, 2020-2030 (US$ Million)
- 12.1.1.2.4 Canada: DNA Extraction, Isolation, and Purification Market, by Source, 2020-2030 (US$ Million)
- 12.1.1.2.4.1 Canada: DNA Extraction, Isolation, and Purification Market, For Microbial DNA by Source, 2020-2030 (US$ Million)
- 12.1.1.2.5 Canada: DNA Extraction, Isolation, and Purification Market, by Application, 2020-2030 (US$ Million)
- 12.1.1.2.5.1 Canada: DNA Extraction, Isolation, and Purification Market, by For PCR Test by Application, 2020-2030 (US$ Million)
- 12.1.1.2.6 Canada: DNA Extraction, Isolation, and Purification Market, by End User, 2020-2030 (US$ Million)
- 12.1.1.3 Mexico: DNA Extraction, Isolation, and Purification Market - Revenue and Forecast to 2030 (US$ Million)
- 12.1.1.3.1 Mexico: DNA Extraction, Isolation, and Purification Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.3.2 Mexico: DNA Extraction, Isolation, and Purification Market, by Method, 2020-2030 (US$ Million)
- 12.1.1.3.2.1 Mexico: DNA Extraction, Isolation, and Purification Market, For Chemical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.3.2.2 Mexico: DNA Extraction, Isolation, and Purification Market, For Physical Methods by Method, 2020-2030 (US$ Million)
- 12.1.1.3.3 Mexico: DNA Extraction, Isolation, and Purification Market, by Sample Type, 2020-2030 (US$ Million)
- 12.1.1.3.4 Mexico: DNA Extraction, Isolation, and Purification Market, by Source, 2020-2030 (US$ Million)
- 12.1.1.3.4.1 Mexico: DNA Extraction, Isolation, and Purification Market, For Microbial DNA by Source, 2020-2030 (US$ Million)
- 12.1.1.3.5 Mexico: DNA Extraction, Isolation, and Purification Market, by Application, 2020-2030 (US$ Million)
- 12.1.1.3.5.1 Mexico: DNA Extraction, Isolation, and Purification Market, by For PCR Test by Application, 2020-2030 (US$ Million)
- 12.1.1.3.6 Mexico: DNA Extraction, Isolation, and Purification Market, by End User, 2020-2030 (US$ Million)
13. North America DNA Extraction, Isolation, and Purification Market-Industry Landscape
- 13.1 Overview
- 13.2 Organic Growth Strategies
- 13.3 Inorganic Growth Strategies
14. Company Profiles
- 14.1 Bio-Rad Laboratories Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Danaher Corp
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 GE HealthCare Technologies Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 F. Hoffmann-La Roche Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Agilent Technologies Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Qiagen NV
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Merck KGaA
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 Illumina Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Takara Bio Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 14.10 Thermo Fisher Scientific Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
- 15.1 About Us
- 15.2 Glossary of Terms